Impact of Basiliximab on the Proportion of Regulatory T Cells and Their Subsets Early After Renal Transplantation: A Preliminary Report
Authors:
- C. YangCYC. Yang
- Y. XueYXY. Xue
- Y.Y. QiuYQY.Y. Qiu
- L. HuLHL. Hu
- X. WangXWX. Wang
- B. YangBYB. Yang
- R. RongRRR. Rong
- M. XuMXM. Xu
- T. ZhuTZT. Zhu
- 1 January 2012
- journal article
- Published by Elsevier in Transplantation Proceedings
- Vol. 44 (1) , 175-178
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81100533, 81170695, 81070595, IHECC07-001, 10DZ2212000, 09411952000)
- Ministry of Health of the People's Republic of China (81100533, 81170695, 81070595, IHECC07-001, 10DZ2212000, 09411952000)
- Science and Technology Commission of Shanghai Municipality (81100533, 81170695, 81070595, IHECC07-001, 10DZ2212000, 09411952000)
This publication has 9 references indexed in Scilit:
- An update on regulatory T cells in transplant tolerance and rejectionNature Reviews Nephrology, 2010
- BasiliximabBioDrugs, 2010
- Impact of Basiliximab on regulatory T-cells early after kidney transplantation: down-regulation of CD25 by receptor modulationTransplant International, 2009
- Regulatory T cells and tolerance inductionClinical Transplantation, 2009
- The T helper 17–regulatory T cell axis in transplant rejection and toleranceCurrent Opinion in Organ Transplantation, 2009
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009
- Foxp3 programs the development and function of CD4+CD25+ regulatory T cellsNature Immunology, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseasesThe Journal of Immunology, 1995